evaluate.com
Get leads like Evaluate — and thousands more
Build targeted lists by tech stack, traffic, and more
Evaluate: The Pharma Intel Powerhouse
Why this $35M revenue giant is the industry's secret weapon for forecasting
In the high-stakes world of pharmaceuticals, where a single drug launch can swing billions in market cap, Evaluate has built an empire on one simple promise: eliminating guesswork. This isn't just data—it's commercial intelligence that shapes billion-dollar R&D decisions.
"Evaluate doesn't just report on the pharmaceutical industry—it predicts it. Their consensus forecasts are the invisible backbone of investor decisions."
The Consensus Engine
What makes Evaluate unstoppable is their consensus forecasting model. While competitors offer raw data, Evaluate synthesizes analyst predictions into unified forecasts. Their 'Evaluate Pharma' report is the gold standard—tracking 20,000+ drugs across 200+ companies. This isn't historical data; it's a crystal ball for 2026 and beyond.
Who Actually Uses This
Evaluate's 236 employees serve a hyper-specific audience: pharmaceutical strategists, biotech investors, and medtech executives. With 52% direct traffic, their users aren't casually browsing—they're returning professionals who treat Evaluate as mission-critical infrastructure. The 4.3/5 Trustpilot rating from 88 reviews suggests high satisfaction among a niche, demanding clientele.
The revenue-to-employee ratio ($150K/employee) signals a high-margin SaaS model typical of enterprise intelligence platforms. Yet their organic search traffic sits at just 37%—a surprising weakness for a content-driven business. This suggests they're either under-optimized for SEO or rely heavily on enterprise sales cycles, where relationships trump discoverability.
- Consensus forecasting: Their core moat—synthesizing analyst predictions into unified data streams
- Orphan drug focus: Specialized coverage of rare disease drugs (evidenced by 'Evaluate Pharma Orphan' keyword)
- 2026 Preview Reports: Forward-looking intelligence that competitors struggle to replicate
- Global pharma growth tracking: Real-time industry growth rate monitoring
The Verdict: A Boring, Profitable Monopoly
Evaluate dominates a niche so specific that giants like Bloomberg and Reuters can't touch them. Their $42.9M funding history suggests steady, profitable growth—rare in today's market. For pharma insiders, Evaluate isn't optional; it's infrastructure.
What tech stack does Evaluate use?
How much traffic does Evaluate get?
Traffic & Engagement
Traffic Sources
Where is Evaluate's audience located?
What keywords does Evaluate rank for?
5 keywordsHow is Evaluate's SEO?
Open Graph Image
https://www.evaluate.com/wp-content/uploads/2026/01/cropped-evaluatefavicon26.png
Meta Tags
Pharma commercial intelligence, news & analysis | Evaluate
Trusted commercial intelligence, consensus forecasts, news and analysis for pharma, biotech and medtech industry - Explore Evaluate
Home
H1 Tags
Schema Types
What is Evaluate's revenue?
Who competes with Evaluate?
Who works at Evaluate?
Loading leads...
What do customers think of Evaluate?
Evaluate
Categories
Activity & Engagement
Contact Information
Reviews (20)
recomended 100% realy good exp :) it…
recomended 100% realy good exp :) it was fast answer and mutch more <3
Great Experience
Simple to understand,Lindsey explained everything about installation and how to use. “Red” our installer was quick, went over everything thoroughly. Highly recommended……….. Thanks
Engineer phoned 20 minutes before…
Engineer phoned 20 minutes before arriving, serviced the gas boiler gave advice on carbon monoxide detectors for my home and also arranged for the radiator in the downstairs toilet to be replaced very pleased with British gas
Sofia the best so helpful
Sofia the best so helpful
One of the most easy resume builder…
One of the most easy resume builder tool. Very easy to use. highly recommend. Loved it
Frequently Asked Questions about Evaluate
What is Evaluate's Revenue?
What does Evaluate do?
How fast is Evaluate growing?
What technologies does Evaluate use?
Who are Evaluate's competitors?
What do customers think of Evaluate?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Evaluate?
Contact Information
Export evaluate.com Data
Download the complete tech stack, analytics, leads, and company data for evaluate.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About evaluate.com
Trusted commercial intelligence, consensus forecasts, news and analysis for pharma, biotech and medtech industry - Explore Evaluate
Company Overview
evaluate.com Social Media
Contact evaluate.com
Phone Numbers
Technology Stack
evaluate.com uses 22 technologies across their website including Vimeo, YouTube Embed, Font Awesome, Adobe Fonts, reCAPTCHA, and more.
Video
Vimeo, YouTube Embed
Fonts
Font Awesome, Adobe Fonts
Security
reCAPTCHA
Programming Languages
PHP
CMS
WordPress
Privacy & Consent
OneTrust
Traffic & Audience
evaluate.com receives approximately 52.1K monthly visitors and ranks #573,152 globally. The website has a bounce rate of 49% with visitors viewing an average of 2.7 pages per visit. Users spend an average of 1:12 on the site.
The majority of evaluate.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is evaluate.com?
What technologies does evaluate.com use?
How do I contact evaluate.com?
What are evaluate.com's social media accounts?
Is evaluate.com hiring?
How popular is evaluate.com?
Related Searches
This page provides publicly available information about evaluate.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit evaluate.com directly at https://evaluate.com.